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IMR-90Alternations of cellular gene expression following an adenovirus type 2 infection of human primary cells
were studied by using superior sensitive cDNA sequencing. In total, 3791 cellular genes were identiﬁed as dif-
ferentially expressed more than 2-fold. Genes involved in DNA replication, RNA transcription and cell cycle
regulation were very abundant among the up-regulated genes. On the other hand, genes involved in various
signaling pathways including TGF-β, Rho, G-protein, Map kinase, STAT and NF-κB stood out among the
down-regulated genes. Binding sites for E2F, ATF/CREB and AP2 were prevalent in the up-regulated genes,
whereas binding sites for SRF and NF-κB were dominant among the down-regulated genes. It is evident
that the adenovirus has gained a control of the host cell cycle, growth, immune response and apoptosis at
24 h after infection. However, efforts from host cell to block the cell cycle progression and activate an anti-
viral response were also observed.
© 2011 Elsevier Inc. All rights reserved.Introduction
By convention, the human adenovirus replication cycle is divided
into two phases, an early and a late phase, which are separated by
the onset of viral DNA replication. Based on temporal changes of the
gene expression pattern as revealed by DNA microarray analysis
(Zhao et al., 2007), adenovirus type 2 (Ad2) infection in human pri-
mary lung ﬁbroblasts can be divided into four periods. The ﬁrst period
is from 0 to 12 h after infection before or shortly after adenoviral gene
expression has commenced. During this time, changes in cellular gene
expression are likely to be triggered by the virus entry process, such
as attachment of virus to cell surface receptors, and its intracellular
transport along microtubules. Toll-like receptors might also be in-
volved in these processes and MyD88 seems to play a central role
(Hartman et al., 2007). Most of the deregulated genes have functions
linked to inhibition of cell growth (Granberg et al., 2006; Zhao et al.,
2007). Therefore, growth suppression is most likely the ﬁrst response
of the host cell to the incoming virus. The second period covers the
time from 12 to 24 h after infection and follows activation of the im-
mediate early E1A gene. During this period, there is an increase in the
number of differentially expressed cellular genes. About 50% of these
genes are involved in cell cycle regulation, cell proliferation and anti-
viral response. The third period extends from 24 to 42 h after infec-
tion. By this time, the virus has gained control of the cellular
metabolic machinery, resulting in an efﬁcient replication of the viralrights reserved.genome. Additional changes in cellular gene expression are modest
during this phase. During the fourth and last period, when the cyto-
pathic effect becomes apparent, the number of down-regulated genes
increases dramatically including many genes involved in intra- and ex-
tracellular structure.
The most intensive battle between the adenovirus and its host
takes place during the second period after adenovirus genes expres-
sion has started. The major functions of the early gene products are
to force the host cell to enter the S phase in order to provide optimal
conditions for viral DNA replication and to suppress the host antiviral
response. Adenoviruses encode several regulatory proteins within
the early regions E1A, E1B, E3, and E4. The immediate-early E1A
gene encodes two regulators of viral and cellular gene expression,
the E1A-243R and E1A-289R proteins. The E1A proteins act as pro-
miscuous transcriptional activators or repressors of cellular genes
(Arany et al., 1995; Bagchi et al., 1990; Bannister and Kouzarides,
1995; Deleu et al., 2001; Flint and Shenk, 1997; Fuchs et al., 2001;
Wu et al., 1987). E1A proteins are essential for promoting the host
cell to enter the S phase. This is achieved by the binding of the E1A
proteins to members of the retinoblastoma tumor suppressor (pRB)
family, thereby releasing the E2F transcription factors, which are acti-
vators of genes required in the S-phase (Bayley and Mymryk, 1994;
Cobrinik, 1996). By microarray analyses it was shown that a signiﬁ-
cant fraction of the up-regulated genes during the early phase of in-
fection are E2F targets (Miller et al., 2007; Zhao et al., 2003, 2007).
E1A-induced cell proliferation also involves interaction with
chromatin-modifying and transcriptional coactivator complexes. The
interaction between E1A and the coactivators p300 and the cyclic
AMP response element-binding protein (CBP) probably disrupts the
Table 1
Summary of sequencing reads and alignment to the human and adenovirus genome.
Mock Ad2-12 hpi Ad2-24 hpi
Total sequencing reads 53,146,621 50,045,456 54,355,211
Alignment to both human
and Ad genome
31,696,418
(59.6%)
30,907,561
(61.8%)
35,346,824 (65.0%)
Alignment to human genome 31,696,017
(100.0%)
29,549,310
(95.6%)
19,424,249 (55.0%)
Alignment to Ad genome 401 (0.0%) 1,358,215 (4.4%) 15,922,575 (45.0%)
116 H. Zhao et al. / Virology 424 (2012) 115–128histone acetyltransferase activity of p300/CBP and the associated
factor PCAF, leading to decreased transcription from a variety of
genes, including those involved in growth arrest, cell differentiation,
and immune evasion (Debbas and White, 1993; Lowe and Ruley,
1993). In addition, E1A interacts with TRRAP, which is a component
of three distinct histone acetyltransferase complexes. Thus, E1A
has the capacity to interact with multiple histone acetyltransferase
complexes and recruit these to viral or selected cellular promoters.
The interaction of E1A with p400/TRRAP (Deleu et al., 2001; Fuchs
et al., 2001) and the co-repressor C-terminal Binding Protein (CtBP)
(Chinnadurai, 2004; Johansson et al., 2005), provides additional
possibilities for E1A to deregulate cellular transcription. It has, more-
over, been shown by Ferrari et al. (2008) that cells are reprogrammed
epigenetically as a result of speciﬁc E1A interactions at different
times after infection. Therefore, the ability of E1A to target different
cellular transcriptional regulators creates a variety of possibilities to
deregulate the cell growth controlling activities of the host. Finally,
E1A can block the growth inhibition mediated by TGF-β pathway
(Coussens et al., 1994a; Datto et al., 1997a; de Groot et al., 1995).
A possible negative consequence of the S-phase induction is that
the binding of E1A to pRb and p300/CBP promotes p53 accumulation,
which leads to the induction of p53-dependent apoptosis (Debbas
and White, 1993; Lowe and Ruley, 1993). E1A can also sensitize
infected cells to TNFα- and TRAIL-induced apoptosis (Chen et al.,
1987; Duerksen-Hughes et al., 1989; Routes and Cook, 1990). Adeno-
viruses have, however, numerous mechanisms, which can block apo-
ptosis. Two E1B proteins, the E1B-55K and E1B-19K, play a major role
in the counteraction of the pro-apoptotic program. E1B-55K binds to
p53 (Yew et al., 1994), which promotes degradation of p53 through
an E4orf6-E3 ubiquitin ligase complex (Punga and Akusjarvi, 2000;
Querido et al., 2001). In spite of these compelling ﬁndings it was re-
cently demonstrated that the p53 dependent genes are still repressed
after infection with a mutant that is unable to express E1B-55K
(Miller et al., 2009). The E1B-19K protein is a viral Bcl-2 homologue
that acts as a broad inhibitor of mitochondria-dependent apoptosis
(Farrow et al., 1995; Han et al., 1996). It can moreover interfere di-
rectly with the activity of p53 when translocated to the mitochondria
(Lomonosova et al., 2005). In addition, E1A also counteracts its own
induction of p53 through sequestering of p300/CBP (Somasundaram
and El-Deiry, 1997). Furthermore, proteins encoded by the E3 tran-
scription unit also inhibit apoptosis. E3-gp19K prevents exposure
of viral peptides on the cell surface by inhibiting the transport of
class I major histocompatibility complex from the ER to the plasma
membrane, as well as inhibiting the loading of peptide by tapasin
(Bennett et al., 1999; Burgert et al., 1987; Wold et al., 1999). The
E3-10.4K and 14.5K (RIDα/β) complex inhibits tumor necrosis factor
alpha (TNFα) and Fas ligand-induced cell death through internaliza-
tion of the death domain containing receptors, which are subsequent-
ly degraded in the lysosome. In addition, the E3-10.4K/14.5K complex
can block the activation of NF-κB by preventing NF-κB from entering
the nucleus, as well as by inhibiting the activity of the kinase complex
IKK (Friedman and Horwitz, 2002). Although E1A is responsible for
the increased TNFα sensitivity (Ames et al., 1990), E1A also balances
this induction by interfering with the transcriptional activity of NF-κB
(Cook et al., 2002) by targeting the p300/CBP co-activators, and by
inhibiting NF-κB acetylation (Jennings-Gee et al., 2006) and IKK inhi-
bition (Shao et al., 1999).
Following the accumulation of E2 gene products, adenovirus DNA
replication starts and the viral transcription switches from the early
to the late mode. Through a shift in splice site selection, E1A expres-
sion is changed from an early preference for the 289R transcriptional
activator to producing the shorter E1A-243R protein during the late
phase of the infection (Chow et al., 1979). The E1A-243R protein
mainly functions as a transcriptional repressor through its capacity
to bind p300/CBP (Jones, 1995). The L4-100 kDa protein expressed
from the major late transcription unit also regulates viral geneexpression and shuts off translation of cellular mRNAs (Cuesta
et al., 2000; Farley et al., 2004; Hayes et al., 1990). A dramatic
down-regulation of cellular gene expression was noticed at very
late stage of infection (Zhao et al., 2007). Most of these genes are in-
volved in maintaining intra- and extracellular structure.
We and others have previously studied the temporal host cell
transcription proﬁles in adenovirus-infected human ﬁbroblasts
using microarray analysis (Granberg et al., 2006; Miller et al., 2007;
Zhao et al., 2003, 2007). More than two thousand unique cellular
genes were identiﬁed as differentially expressed in infected cells as
compared to uninfected cells. In our previous studies, nine time
points from 2 up to 48 h after infection were examined. Several im-
portant cellular functions were deregulated during the infectious
cycle. The microarray studies represent a starting point in the unra-
veling of the dynamics of the transcriptome during a virus infection.
With the development of high-throughput sequencing technologies,
the transcriptome can be explored on a genome-wide scale at single
base pair resolution. This methodology has clear advantages when
compared to microarray analysis. Firstly, the measurements of tran-
scription levels are much more precise. Secondly, the entire cellular
genome can be interrogated, including non-coding genes and inter-
genic regions. Here, we describe a study of host cell transcription pro-
ﬁles by sequencing of the total RNA pool in adenovirus infected cells.
Results and discussion
RNA expression proﬁles in adenovirus infected human primary lung
ﬁbroblasts
Here, we have applied cDNA sequencing to study differences in
the cell transcription proﬁles at different times after adenovirus infec-
tion. The design of the experiments was similar to that used in our
previous microarray study (Zhao et al., 2007). Human primary lung
ﬁbroblasts (IMR-90) were synchronized prior to infection by contact
growth inhibition and infection was performed at a multiplicity of
100 FFU per cell. Cells were harvested at 12 (Ad-12 hpi) and 24 hpi
(Ad-24 hpi), as well as after mock infection and total RNA was
extracted to be used for the cDNA library preparation. Previous re-
sults show that 12 and 24 hpi represent critical time points in the ad-
enovirus infectious cycle (Zhao et al., 2007). At 12 hpi, expression of
cyclin E1 is detected, demonstrating that the infected cells had pro-
gressed into the late G1 phase of the cell cycle. At 24 hpi, adenovirus
DNA replication has started indicating that the late phase of the infec-
tion has begun. Thus, examination of cellular gene expression at
12 hpi and 24 hpi should reﬂect two critical stages of the infectious
cycle.
Three cDNA libraries, mock, Ad2-12 hpi and Ad2-24 hpi, were se-
quenced and yielded 50–54 million 76 bp long sequence reads per
sample, as shown in Table 1. More than half of the reads from each
sample (59.6–65%) could be aligned to the human and adenovirus
genomes. The fraction of reads that aligned to the human reference
genome decreased following adenovirus infection, from 31.7 million
reads in the mock infected sample to 19 million reads at 24 hpi. Cor-
respondingly, the reads aligned to the adenovirus genome increased
dramatically, from 401 to 15.9 million reads. The 401 reads that were
aligned to the adenovirus genome in the mock sample represented
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45% matched the adenovirus genome, indicating a very efﬁcient
infection.
Expression of adenovirus genes occurred in a stepwise pattern. At
12 hpi, only the early genes, E1A, E1B, E3 and E4 were expressed
(data not shown) and expression of E1A and E1B was lower as com-
pared to the expression of E2A, E3 and E4. The complete absence
of expression from the major late promoter was conspicuous. At
24 hpi, in contrast, the late viral genes were expressed at a very
high level, indicating that the infection had efﬁciently proceeded
into the late phase. Huge amounts of sequence reads covering exonic,
intronic and intergenic regions were obtained in this study. However,
in the present study we focused on the analysis of cellular exonic
sequences.Identiﬁcation of 3791 cellular genes that were differentially expressed
during the adenovirus infection
Using a 2-fold cut off level, 3791 cellular genes were found to be
differentially expressed at 12 and 24 hpi. Among them, 1267 and
3683 cellular genes were identiﬁed at 12 and 24 hpi, respectively.
Most of the differentially expressed genes identiﬁed at 12 hpi were
sustained at 24 hpi, but with more dramatic changes. Only 108
genes were exclusively deregulated at 12 hpi. The 3791 differentially
expressed genes were functionally annotated based on the DAVID
(the Database for Annotation, Visualization and Integrated Discovery)
bioinformatics resource. Genes in the output list were classiﬁed into
gene groups, which were deﬁned as functional categories. The gene
members in each category shared common biological characteristics.
As shown in Table 2A, cellular genes involved in DNA replication
obtained the highest score value (=P-value of 10−21). Cell cycle
genes received the second highest score followed by genes participat-
ing in many cellular biosynthetic processes. Genes involved inTable 2
DAVID functional annotation of 3791 differentially expressed genes identiﬁed
from both Ad-12 hpi and Ad-24 hpi (A), differentially expressed genes identiﬁed at
Ad-12 hpi (B) and at Ad-24 hpi (C).
Category Functional annotation Enrichment score
A
1 DNA replication 21.4
2 Cell cycle 14.1
3 Regulation of biosynthetic process 8.5
4 Regulation of cell growth 6.0
5 Spindle/microtubule organization 5.7
6 Angiogenesis/wound healing 5.4
7 Regulation of cell proliferation 4.9
8 Organ development 4.5
9 Regulation of cell differentiation 4.3
B
1 DNA replication 10.9
2 Regulation of biosynthetic process 6.4
3 Organ development 6.0
4 Regulation of cell proliferation 4.4
5 Cell cycle 3.6
C
1 DNA replication 23.6
2 Cell cycle 14.5
3 Regulation of biosysnthetic process 7.2
4 Regulation of cell growth 6.8
5 Regulation of cell proliferation 5.0
6 Spindle/microtubule cytoskeleton organization 4.8
7 Angiogenesis/wound healing 3.9
8 Regulation of cell differentiation/developmental 3.8
9 Cytoskeleton organization 3.8
10 Regulation of apoptosis 3.7
11 Chromosome organization/modiﬁcation 3.5regulation of cell growth followed next. Genes implicated in wound
healing and intracellular structure also received high scores.
In order to compare genes that were deregulated at different time
points, data obtained with the different cDNA libraries were
analyzed separately and the results were shown in Table 2B and C.
Although the number of differentially expressed genes increased
dramatically from 12 hpi to 24 hpi, and more cellular functional
pathways were affected at 24 hpi, many key targets were similar.
Cellular genes involved in DNA replication and the regulation of bio-
synthetic processes were the most signiﬁcantly regulated genes at
both time points. Genes involved in the cell cycle and cell growth be-
came more prominent at 24 hpi. A striking difference was that genes
involved in angiogenesis/wound healing, apoptosis and cytoskeleton
organization became signiﬁcant at the later time point.
Clustering of differentially expressed genes and functional annotation of
the clusters
Based on their expression patterns, the 3791 differentially
expressed genes were broadly grouped into 6 clusters using Genesis
(Fig. 1). Cluster 1 contained 13 genes, which were down-regulated
only at 12 hpi and then returned to base line at 24 hpi. In contrast,
genes in cluster 2 were up-regulated only at 12 hpi. More than half
of the deregulated genes (1955 genes) were up-regulated and in-
cluded into clusters 3 and 4. Genes in cluster 3 were up-regulated al-
ready at 12 hpi and remained up-regulated at 24 hpi, whereas up-
regulation of genes in cluster 4 was seen ﬁrst at 24 hpi. Nearly half
of the differentially expressed genes were in cluster 4. Cluster 5 con-
tained 1056 genes and their expression had decreased at 12 hpi and
the deregulation was maintained at 24 hpi. Genes in cluster 6 were
down-regulated at 24 hpi but not at 12 hpi. Among the deregulated
genes, 71% were down-regulated at 12 hpi but the number was de-
creased to 35% at 24 hpi. More genes (65%) were activated at
24 hpi. Apparently, there was a switch from repression to activation
of cellular gene expression. This seems rational since the virus
needs to suppress the host antivirus response early after infection
whereas late after infection genes involved in DNA and protein syn-
thesis need to be activated for efﬁcient virus production.
The functional annotations of genes in the 6 clusters were based
on DAVID analysis as summarized in Table 3. Unfortunately, the
genes in clusters 1 and 2 could not be functionally annotated because
of their small number. However, by searching for functions, mostly
using the Stanford data base SOURCE (http://smd.stanford.edu/cgi-
bin/source/sourceSearch), Genecards (http://www.genecards.org)
and PubMed (http://www.ncbi.nlm.nih.gov/pubmed), it became
apparent that these two clusters contained genes with interesting
functions. Cluster 1, for instance, included CDC20 and UBE2C, which
were directly involved in cyclin ubiquitination and degradation, and
HJURP, CSRP2 and EGR2 implicated in control of cell growth. Cluster
2 included a diverse set of genes involved in various biosynthesis
processes. In addition, a broad range of genes involved in cellular sig-
naling such as G-protein signaling, Wnt and Notch signaling were
also transiently activated. These genes probably represented the
ﬁrst wave of deregulation of host cell gene expression.
Clusters 3 and 4 contained up-regulated genes, ﬁrst detected at 12
and 24 hpi, respectively. Only two cellular functions were found to be
signiﬁcant in cluster 3, both related to DNA replication and nucleic
acid biosynthesis. Although genes involved in cell cycle regulation
did not stand out as signiﬁcant, there were several key players in
the G1/S progression in this cluster, such as Cyclin E, Cyclin F, CDC 7
and E2F6. Cluster 4, which was the largest cluster, included genes in-
volved in the biosynthesis of DNA, RNA and protein, as well as the
progression of the G1/S phase of the cell cycle. Examples of genes in-
volved in DNA replication were DNA polymerases (POLA1, POLD1,
POLD3, POLE, POLE2), all the minichromosome maintenance complex
components (MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MCM8,
Fig. 1. The clusters of differentially expressed genes that were generated by Genesis. Each gene was normalized around zero with the “Normalize genes” function in Genesis and
then k-means clustered. The purple line was the average expression pattern.
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Genes implicated in cell cycle regulation included cyclins (CCNA2
and CCNB2), cyclin-dependent kinases (CDK1, CDK2, CDK4,
CDK11B), and the cyclin-dependent kinase inhibitors (CDKN2A and
CDKN2C) as well as CDC6, CDC23, CDC25A, CDCA2, CDCB29. The
important transcription factors E2F1, E2F6 and E2F7 were also in
this cluster.
Clusters 5 and 6 included down-regulated genes detected from 12
and 24 hpi, respectively. DAVID annotation analysis showed that
genes in cluster 6 involved two cellular functions, namely vesicle traf-
ﬁcking and cytoskeletal components with relative low enrichment
scores. However, the repression of genes involved in protein trans-
port was broad and highlighted by genes in Rab subfamily (Rab14,
Rab3A, Rab40C, Rab5B and Rab6C), involved in intracellular vesicleTable 3
DAVID functional annotation of genes in clusters 3, 4, 5 and 6.
Cluster Category Functional annotation Enrichment
score
3 1 Regulation of nucleic acid biosynthetic process 5.9
2 DNA replication 3.1
4 1 DNA replication 31.7
2 Cell cycle 30.9
3 RNA processing 11.1
4 Chromatid segregation/chromosome condensation 7.3
5 Cellular macromolecular complex subunit
organization
4.5
6 Spindle/microtubule organization 4.3
7 Nucleic acid biosynthetic process 3.6
8 Telomere organization/maintenance 3.4
9 Amino acid biosynthetic/metabolic process 3.2
5 1 Regulation of signal transduction 14.6
2 Negative regulation of biological/metabolic process 10.9
3 Cytoskeleton organization 9.3
4 Angiogenesis/wound healing 8.7
5 Tissue/organ development 7.8
6 Regulation of apoptosis 7.2
7 Regulation of cell proliferation 7.2
8 Regulation of cell development/differentiation 7.1
9 Regulation of cell growth/size 6.3
10 Regulation of cell motion/migration 5.9
6 1 Vesicle trafﬁcking/protein transport 3.4
2 Cytoskeletal components/tissue morphogenesis 3.3formation, trafﬁcking and membrane fusion, and the Rho subfamily
(such as RhoB, RhoT1) involved in regulation of cytoskeleton, as
well as Rho related genes (ARHGEF1, and ARHGAP22). In addition, a
group of genes involved in vesicle trafﬁcking, such as the Sec23/
Sec24 family (Sec24A, C and D, Sec23A) and Sec31 family (Sec 23A),
as well as syntaxins (STX2 and STX7), synapotagmin 1 (SYT1), synta-
philin (SNPH and Rad21L1) and SNAP23, was also present in cluster
6. Furthermore, a large number of genes in the solute carrier family,
such as SLC4A4, SLC5A3, SLC17A5, SLC25A30, SLC25A43, SLC26A1,
SLC26A11, SLC30A1, and SLC35F5, were also included in the protein
transport category. In contrast, genes involved in cellular structure
were restricted, comprising collagen genes (COL1A1, COL5A1, COL6A3,
COL8A1, COL12A1 and COL13A1), and a few genes encoding
microtubule-associated proteins (MACF1, MAP1B and MAP2). Finally,
a group of important genes implicated in TGF-β signaling (LTBP2,
SMURF1, TGFBR2, BMPR2 and SMAD7) was present in cluster 6. The
low enrichment score of cluster 6 suggested that the deregulation of
genes involved in vesicle trafﬁcking/protein transport and cellular
structure was still limited at 24 hpi. This is consistent with our previous
microarray study showing that down-regulation of the cytoskeleton
and protein transport occurred at a very late stage of the infection,
after 42 h (Zhao et al., 2007).
Cluster 5 contained a large set of genes, involved in several cellular
functions and pathways (see Table 3). Genes implicated in cell signal-
ing pathways were the most signiﬁcantly suppressed gene group
(category 1). In addition to TGF-β and NF-κB signaling pathways,
genes involved in G-protein, Map kinase, as well as in FADD and
FAS-mediated apoptosis pathway were also found to be down-
regulated. When resubmitted to DAVID gene annotation analysis,
genes included in category 1 could be further divided into positive
and negative regulation of signaling pathways (data not shown
here). Genes involved in TGF-β pathway were the most signiﬁcant
in the negative group, whereas genes involved in apoptosis were
the most prominent in the positive group.
Genes in category 2 included genes involved in negative regula-
tion of biological and metabolic processes, covering a very broad
range of functions, such as growth, signaling, and apoptosis, which
partially overlap with functions in the ﬁrst annotation cluster. In con-
trast, genes in category 3 were more focused on cellular structure.
Nearly half of the genes encode actin (ACTA1, ACTC1) and actin-
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merization such as ARPC4, ARPC5, CNN1, CNN2, CNN3, FMN2, FMNL1,
TMSB4X, TMSB4XP1, TMSB4XP2, TMSL3 and VASP. Category 4 included
genes mainly involved in angiogenesis, including growth factors (FGF1,
FGF2 CTGF, VEGFC TGFB and ANGPL4), receptors (FLT1, TGFBR1 and
TNFRSF12A), and extracellular matrix and remodeling enzymes
(MMP19, PLAT, PLAU, THBS1, CD9, CDH2 and RECK), as well as the
angiogenic inducer CYR61. Down-regulation of these genes might sup-
press wound healing during the infection. In addition, several stress-
induced genes, such as TXNRD1, HIF1A, ERCC2, and wound healing
protein TPM1 were down-regulated.
Consensus binding sites for transcription factors in the promoter regions
of differentially expressed genes
To investigate the mechanism by which the deregulation of cellu-
lar gene expression was accomplished, genes in the 6 clusters were
scanned for the presence of consensus transcription factor binding
sites using Transﬁnd (Kielbasa et al., 2010), a software tool that pre-
dicts the afﬁnity of a transcription factors to the promoter regions
(−300 to +100). The gene list of each cluster was submitted as a
positive set. The enrichment of transcription factor binding sites
was measured relative to a gene set comprising all of the detected
genes with more than two reads. The transcription factor matrix
was deﬁned as signiﬁcant if the corresponding false discovery rate
(FDR) was b0.02. Table 4A–C shows the output from the Transﬁnd
analysis of the gene sets in clusters 3, 4 and 5, respectively. The
over-represented transcription factor binding sites were listed based
on the order of signiﬁcance. No signiﬁcant enrichment of transcrip-
tion factor binding sites was identiﬁed for the genes in clusters 1, 2
and 6. As indicated in Table 4A, for the genes in cluster 3, AP2 and
E2F binding sites were highly signiﬁcant with FDRb0.000058.
Thirty-eight genes contained AP2 binding sites, which represented
6.9% of the genes in this cluster, whereas only 2.8% of the genes in
the control set contained this binding site. The same number ofTable 4
Transﬁnd analysis of over-represented transcription factor binding site motifs in the
promoter region of genes in cluster 3 (A), cluster 4 (B) and cluster 5 (C).
Rank TF matrix p-value FDR Hits in
positive set
Hits in
negative set
A
1 AP2_Q3 0.0000008 0.0000577 38 (6.934%)a 462 (2.789%)b
2 E2F_Q6_01 0.0000008 0.0000577 38 (6.934%) 462 (2.789%)
3 GC_high 0.0000008 0.0000577 38 (6.934%) 462 (2.789%)
4 AHRHIF_Q6 0.0000133 0.0007208 35 (6.387%) 465 (2.8075%)
5 E2F_02 0.0003661 0.0132402 31 (5.657%) 469 (2.831%)
6 SP1_Q4_01 0.0003661 0.0132402 31 (5.657%) 469 (2.831%)
B
1 E2F_02 0.0000000 0.000000013 98 (7.413%) 402 (2.546%)
2 E2F_Q6_01 0.0000000 0.000000013 96 (7.262%) 404 (2.558%)
3 E2F_01 0.000000001 0.000000049 79 (5.976%) 421 (2.666%)
4 CREBATF_Q6 0.000001626 0.000070582 69 (5.22%) 431 (2.729%)
5 CpG_high 0.000001626 0.000070582 69 (5.22%) 431 (2.729%)
6 CREBP1CJUN_01 0.000077859 0.00241363 63 (4.766%) 437 (2.767%)
7 ATF4_Q2 0.000077859 0.00241363 63 (4.766%) 437 (2.767%)
8 ATF3_Q6 0.000245532 0.006660051 61 (4.614) 439 (2.78%)
9 CREBP1_Q2 0.000424329 0.009207931 60 (4.54%) 440 (2.786%)
10 CREB_Q2_01 0.000424329 0.009207931 60 (4.54%) 440 (2.786%)
11 ATF1_Q6 0.000719998 0.014203588 59 (4.46%) 441 (2.793%)
C
1 SRF_01 0.000000833 0.000180679 59 (5.65%) 441 (2.74%)
2 NFκB65_01 0.000031438 0.003411022 54 (5.17%) 446 (2.78%)
3 EGR1_01 0.000116539 0.00842965 52 (4.98%) 448 (2.79%)
a The number and percentage of genes that contain speciﬁc transcription factor
binding site among genes in the cluster.
b The number and percentage of genes that contain speciﬁc transcription factor
binding site among all expressed genes.genes contained E2F binding sites. However, only two genes (RBL1
and CBX7) contained both AP2 and E2F binding sites. The genes
with putative AP2 binding sites were involved in diverse cellular sig-
naling pathways. Another signiﬁcant group of genes with AP2 sites
was that involved in DNA, RNA and protein synthesis. The most im-
portant group of genes containing E2F binding sites, on the other
hand, was that involved in cell cycle and DNA replication.
Following the progression of the infection, more genes were acti-
vated at 24 hpi (cluster 4). Thus, it would be expected that a new set
of transcription factors would be identiﬁed by Transﬁnd. As shown in
Table 4B, the E2F binding site was still the most overrepresented.
Three variants of E2F binding sites were each present in 98, 97and
79 genes, respectively. There were however, overlaps between
these variants. Taken together a total of 182 genes contained a puta-
tive E2F binding site. The transcription factor binding sites for sever-
al members of the ATF/CREB family, such as ATF1, ATF2 (CREBP1),
CREB, ATF3 and ATF4 were also conspicuous. There were many over-
laps between genes with these binding sites, and in total 137 genes
contained a putative binding site for any of the transcription factors
in the ATF/CREB family. As indicated by DAVID analysis, genes in
cluster 4 were mainly involved in DNA replication, cell cycle, RNA
and protein synthesis, or related metabolic processes.
A special set of transcription factor binding sites was identiﬁed in
the promoter region of the differentially expressed genes in cluster 5
(Table 4C), which included genes that were down-regulated at
24 hpi. Transcription factor binding sites for SRF, NF-κB and EGR1
had the highest scores in this cluster. Fifty-nine genes (5.65%) con-
tained SRF binding sites. SRF is a ubiquitous nuclear protein that
binds to the serum response element (SRE) associated with a variety
of genes including so-called immediate early genes like c-fos, fosB,
junB, EGR1, EGR2 and HSP70. They play a pivotal role in transferring
extracellular signals into speciﬁc nuclear responses (Chai and
Tarnawski, 2002). Fifty-four genes (5.17%) harbored NF-κB binding
sites. NF-κB mediates responses to stimuli such as stress and infec-
tion, and plays a key role in regulating the immune response to
infection.
Expression of genes that encoded these key transcription factors
was included in Table 5. Although the binding sites for AP2 and E2F
were the most signiﬁcant among the genes up-regulated from
12 hpi (in cluster 3), the expression proﬁle of these two families
of transcription factors was very different. Among AP2 family, only
AP2A (or TFAP2A) was expressed, and its expression was decreasing
with time after infection. Among eight E2F species, ﬁve E2F species
were found to be expressed, and their expression increased dramat-
ically following the progression of infection. For example, the
expression of E2F2 was up 12 fold at 12 hpi and 87 fold at 24 hpi as
compared with non-infected cell. The transcription of different
members of the ATF/CREB family was very diverse; only ATF4 and
ATF5 were up-regulated whereas the rest of them were either
down-regulated or unchanged. Expression of both SRF and NF-κB
decreased more than 2-fold, whereas EGR1 declined more than
17-fold. The decline in EGR1 expression might be a consequence of
its dependence on SRF.
Control of cell growth and cell cycle
Deregulation of the host cell cycle is a prerequisite for a successful
adenovirus infection in order to force the cell to enter the S phase.
Binding of E1A to pRb results in the release of transcription factor
E2F, which thereby activates transcription of genes required for the
S phase induction and DNA replication. Our results showed that
genes involved in the DNA replication and cell cycle regulation were
the most signiﬁcant up-regulated genes. Transﬁnd analysis indicated
that the most over-represented transcription factor binding site in
the up-regulated genes either from 12 hpi (cluster 3) or 24 hpi (clus-
ter 4) was E2F. In addition to the dramatic increase in E2F transcripts,
Table 5
Expression of putative transcription factors identiﬁed by Transﬁnd.
Gene symbol Fold change Sequencing reads
Ad-12 hpi Ad-24 hpi Mock Ad-12 hpi Ad-24 hpi
TFAP2A −2.5a −3.6b 451.8 183.6 123.9
E2F1 3.1 12.1 127.2 389.6 1539.7
E2F2 12.8 87.9 3.9 50.1 344.3
E2F6 1.6 2.3 235.2 385.8 533.0
E2F7 −1.2 2.9 84.9 68.4 247.3
E2F8 2.1 13.2 11.9 25.3 156.8
E2F3 −1.3 −1.5 204.7 157.0 137.1
E2F4 −1.2 −1.3 1128.5 927.0 865.7
E2F5 1.6 −1.1 153.1 239.1 137.4
ATF1 −1.2 1.2 110.3 93.7 127.0
ATF2/CREBP1 1.1 −1.6 127.9 139.5 78.3
ATF3 1.0 1.1 258.2 266.7 279.0
ATF4 1.1 2.1 5458.4 5739.4 11,519.4
ATF5 1.4 2.0 455.8 649.5 902.7
ATF6 1.3 1.8 248.6 333.5 439.5
ATF7 1.1 −2.4 478.8 514.6 197.6
CREB1 1.0 1.1 115.5 118.5 132.8
SRF −1.2 −2.3 944.6 787.4 406.0
NFKB2 −1.4 −2.4 2499.9 1760.7 1063.4
EGR1 −3.3 −17.1 871.3 267.4 51.0
a Fold change in gene expression (sequencing reads) between infected Ad-12 hpi
and uninfected cells (mock).
b Fold change in gene expression (sequencing reads) between infected Ad-24 hpi
and uninfected cells (mock).
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(Table 6). Furthermore, the key regulators of G1 to S phase progres-
sion, the cyclin-dependent kinases, CDK2 and CDK4, as well as their
cyclin partners, CCNA2, CCNE1 and CCNE2, were also up-regulated.
Moreover, the expression of the positive regulator of CDK2/CCNE,
CDC25A, increased 26-fold, whereas their inhibitors CDKN1A (p21)
and CDKN1C decreased signiﬁcantly. Furthermore, expression of S-
phase kinase-associated protein 2 (SKP2), a component of the E3 li-
gase that targets CDKN1A for degradation, increased. The activation
of the cell cycle is thus massive.
As another over-represented transcription factor binding site in
the up-regulated genes from 12 hpi (cluster 3), AP2 is known to act
as tumor suppressor genes and regulates speciﬁc genes involved in
cell cycle and cell death (Gee et al., 1999; Orso et al., 2008). The
genes identiﬁed here that contained the AP2 transcription factor
binding site were involved in various signaling pathways (MAK4P2,
VAV2, POFUT1, PDE7A, SARM1, ARRB1, CMTM4, CACNA1H, ATP2A3,
GNAZ, EFNA5 and PTPN3), cell cycle (RBL1 and CCNF) and DNA dam-
age response (RBM38 and USP28). However, among ﬁve members of
AP2 family, only AP2Awas found to be expressed at a signiﬁcant level,
which decreased with time of infection. It could argue that the pro-
tein level of AP2A probably remained relatively stable during the
early stage of infection. In the contrast to the E2F binding site which
was present in the up-regulated genes both from 12 hpi and 24 hpi,
the AP2 binding site was only signiﬁcant in the genes up-regulated
from 12 hpi, suggesting a role of AP2A during the very early stages
of infection.
It could be speculated that one of the important conﬂicts between
the host cell and the virus in cell cycle control was mediated by AP2
and E2F. Inhibition of the cell growth and cell cycle progression
mediated by AP2 probably represents attempts by the anti-viral de-
fense of the host during the early stage; whereas the activation of
E2F by adenovirus E1A is a counterstrike by the virus. To overcome
the loss of functional pRB due to the sequestration by E1A, the host
cell increased expression of pRB and p107 (RBL1) 2.3 and 7.6 times,
respectively. Another possible countermeasure was to up-regulate
the expression of RBM38, an RNA-binding protein that binds to the
3′-utr of CDKN1A transcripts, thereby maintaining the stability of
CDKN1A transcripts. It was noteworthy that both p107 and RBM38contain AP2 binding sites. Furthermore, the increased expression of
the negative regulators WEE1, CDKN2A and CDKN2C probably also
represents an anti-viral effect.
In line with the activation of E2F, 219 up-regulated genes con-
tained potential E2F binding sites within the promoter region (data
not shown here). These genes included DNA polymerases (POLA1,
POLD1, POLD3, POLE), replication factors (RFC2, 4 and 5), replication
proteins RPA1 and RPA2, the minichromosome maintenance com-
plex components (MCM2-9) and many histones (HIS2H4A and B,
HIST2H2BE, HIST1H2BE 2BH, 2AK, 2BK and 2BJ, HIST1H4E and 4H,
HIST1H3G), indicating that cellular DNA replication components
were required to replicate the viral DNA efﬁciently. It is, on the
other hand, difﬁcult to see that the up-regulation of the histone
genes would be in the interest of the virus as the viral DNA is covered
by virus-encoded proteins.
Deregulation of cellular genes by the ATF/CREB transcription factor
The ATF/CREB transcription factor family appeared also to be im-
portant for up-regulation of many genes as revealed by Transﬁnd
(Table 4B). At least 5 different members of CREBP1, ATF4, ATF3,
CREB and ATF1, were predicted to be involved in gene activation.
However, when lists of target genes were compared, we found that
the majority of the genes contained more than one binding site for
ATF/CREB, allowing heterodimeric partners to bind and participate
in the activation. In total, 137 target genes contained any type of
ATF/CREB binding site. Members of the ATF/CREB family have di-
verse functions controlling cell proliferation and apoptosis. Our
functional analysis indicated that the deregulated genes with ATF/
CREB binding sites were involved in DNA metabolism (such as DNA
mismatch repair, chromosomal structure, chromosome condensa-
tion and segregation) and RNA metabolism (such as transcription
regulation and RNA processing). In addition, several members of
ATF/CREB, like ATF2, ATF3 and ATF6, play a role in mediating stress
response. Accordingly, several genes, which encoded negative regu-
lators of the cell cycle such as WEE1, CDKN2A, CDKN2C and RB1 had
ATF/CREB binding sites.
Activation of WNT signaling pathway
Many signaling pathways were targeted during adenovirus infec-
tion. Activation of Wnt signaling pathway appeared to be one of the
most clear-cut. All detected receptors (FZD1, FZD5, FZD8 and FZD9)
and co-receptors (LRP3, LRP4, LRP6 and LRP8) were up-regulated
(Table 7), whereas the expression of inhibitors (MFRP, DKK1 and
SFRP1) was down-regulated. Furthermore, the expression of Zinc ﬁn-
ger protein SNAI2, a transcriptional repressor that binds to E-box mo-
tifs and represses E-cadherin transcription, decreased signiﬁcantly.
Notably, the expression of one well-known Wnt target gene, BIRC5
(Survivin), an anti-apoptotic protein, was up-regulated at 24 hpi.
However, inhibition of the pathway was also seen, e.g. suppression
of ligands WNT2, WNT5A and WNT5B and activation of APC2 expres-
sion, which targeted β-catenin for degradation. These effects were
likely to be part of the cellular antiviral response. Activation of the
Wnt pathway was rapid. Most of the deregulation had occurred at
12 hpi. So far, activation of the Wnt signaling pathway in adenovirus
infected cells has only been shown at a transcriptional level. Howev-
er, activation of the Wnt pathway has been demonstrated for other
viruses such as a polyoma virus (JCV), Epstein-Barr virus (EBV) and
Kaposi's sarcoma-associated herpesvirus (KSHV) (Enam et al., 2002;
Fujimuro and Hayward, 2003; Morrison et al., 2003). Different strate-
gies such as interaction with β-catenin (JCV), interaction with the
negative regulator GSK-3β, which leads to stabilisation of the β-
catenin (KSHV), or activation of the PI3K/Akt pathway which leads
to inactivation of GSK3ß (EBV) have been seen.
Table 6
Expression of genes directly involved in cell cycle progression.
Gene symbol Gene name Fold change Sequencing reads
Ad-12 hpi Ad-24 hpi Mock Ad-12 hpi Ad-24 hpi
CCNA2 Cyclin A2 −1.1a 3.5b 110.1 98.6 386.2
CCNB1IP1 Cyclin B1 interacting protein 1 1.0 2.2 1155.3 1172.1 2491.8
CCND1 Cyclin D1 −1.8 −7.3 11,835.0 6629.2 1619.9
CCNE1 Cyclin E1 5.4 6.3 206.9 1108.1 1303.8
CCNE2 Cyclin E2 8.4 22.3 24.4 205.3 543.2
CCNF Cyclin F 2.1 1.9 126.7 262.1 240.2
CCNJL Cyclin J-like −1.2 −4.6 84.3 69.2 18.1
CCNL2 Cyclin L2 −1.3 −2.4 4408.6 3275.5 1803.1
CCNT1 Cyclin T1 2.2 2.2 96.8 215.9 209.1
CCNYL1 Cyclin Y-like 1 −1.1 −2.3 125.8 113.9 53.6
CDC123 Cell division cycle 123 homolog (S. cerevisiae) 1.0 2.0 517.8 528.9 1043.5
CDC2 Cyclin-dependent kinase-1 −1.1 7.1 206.1 196.3 1461.3
CDC20 Cell division cycle 20 homolog (S. cerevisiae) −2.2 −1.2 420.6 188.0 357.4
CDC23 Cell division cycle 23 1.4 2.6 135.9 196.3 352.2
CDC25A Cell division cycle 25 homolog A (S. pombe) 8.0 26.1 106.5 855.7 2781.2
CDC2L1 Cell division cycle 2-like 1 1.1 2.0 2438.4 2682.3 4957.6
CDC42EP2 CDC42 effector protein (Rho GTPase binding) 2 −1.1 −2.8 525.4 486.8 187.1
CDC42EP3 CDC42 effector protein (Rho GTPase binding) 3 −2.7 −8.5 1452.2 538.1 170.5
CDC45L Cell division cycle 45 homolog 2.0 23.6 52.4 102.9 1233.8
CDC6 Cell division cycle 6 homolog (S. cerevisiae) 3.7 21.8 65.2 240.6 1423.3
CDC7 Cell division cycle 7 homolog (S. cerevisiae) 6.4 12.6 32.0 203.7 404.2
CDCA2 Cell division cycle associated 2 −1.4 2.3 32.6 23.1 76.0
CDCA3 Cell division cycle associated 3 −1.5 3.0 149.7 96.8 449.0
CDCA4 Cell division cycle associated 4 2.0 4.0 412.8 831.8 1635.4
CDCA5 Cell division cycle associated 5 1.2 10.7 145.9 180.9 1560.2
CDCA7 Cell division cycle associated 7 4.6 7.2 124.5 572.2 901.8
CDCA7L Cell division cycle associated 7-like 2.1 5.1 388.0 822.8 1965.3
CDCA8 Cell division cycle associated 8 −1.7 2.9 149.5 87.7 436.4
CDK2 Cyclin-dependent kinase 2 2.4 6.1 503.6 1208.3 3092.0
CDK4 Cyclin-dependent kinase 4 1.2 2.7 1451.1 1796.7 3922.0
CDK5R1 Cyclin-dependent kinase 5. regulatory subunit 1 (p35) 6.8 6.1 24.1 163.4 147.4
CDK6 Cyclin-dependent kinase 6 −1.5 −3.8 503.7 331.4 134.0
CDK7 Cyclin-dependent kinase 7 −1.8 −3.9 315.7 176.0 80.0
CDKAL1 CDK5 regulatory subunit associated protein 1-like 1 1.3 2.9 48.1 63.0 140.4
CDKL3 Cyclin-dependent kinase-like 3 −1.1 5.1 31.2 29.3 159.3
CDKN1A Cyclin-dependent kinase inhibitor 1A (p21. Cip1) 1.6 −2.7 14,596.5 23,466.6 5492.1
CDKN1C Cyclin-dependent kinase inhibitor 1C (p57. Kip2) −1.1 −3.3 162.3 143.4 49.1
CDKN2A cyclin-dependent kinase inhibitor 2A −1.1 2.0 1045.6 950.2 2134.1
CDKN2AIP CDKN2A interacting protein 1.3 2.3 136.4 179.3 318.6
CDKN2BAS CDKN2B antisense RNA 1 11.6 53.3 0.9 10.7 49.2
CDKN2C Cyclin-dependent kinase inhibitor 2C (p18. inhibits CDK4) 1.1 2.0 179.2 200.3 364.6
CKS1B CDC28 protein kinase regulatory subunit 1B −1.3 1.7 290.1 218.7 494.6
RB1 Retinoblastoma 1 1.3 2.3 75.5 98.1 174.5
RBBP4 Retinoblastoma binding protein 4 1.1 2.4 656.1 710.9 1587.7
RBBP6 retinoblastoma binding protein 6 2.2 3.9 253.8 568.4 988.2
RBBP7 Retinoblastoma binding protein 7 1.2 2.4 755.2 900.9 1816.6
RBBP8 Retinoblastoma binding protein 8 1.8 4.5 270.1 485.8 1220.5
RBBP9 Retinoblastoma binding protein 9 1.9 2.5 38.1 73.9 96.1
RBL1 Retinoblastoma-like 1 (p107) 4.4 7.6 36.5 159.6 278.7
E2F1 E2F transcription factor 1 3.1 12.1 127.2 389.6 1539.7
E2F2 E2F transcription factor 2 12.8 87.9 3.9 50.1 344.3
E2F6 E2F transcription factor 6 1.6 2.3 235.2 385.8 533.0
E2F7 E2F transcription factor 7 −1.2 2.9 84.9 68.4 247.3
E2F8 E2F transcription factor 8 2.1 13.2 11.9 25.3 156.8
SKP2 S-phase kinase-associated protein 2 (p45) 3.8 10.3 181.8 693.9 1869.6
PCNA Proliferating cell nuclear antigen 3.0 7.1 1547.9 4599.2 10,961.5
WEE1 WEE1 homolog (S. pombe) 2.7 4.0 188.4 500.7 753.7
TFDP1 Transcription factor Dp-1 1.6 3.6 1452.0 2364.7 5247.6
TFDP2 Transcription factor Dp-2 (E2F dimerization partner 2) 2.8 4.1 40.8 115.7 168.5
a Fold change in gene expression (sequencing reads) between infected Ad-12 hpi and uninfected cells (mock).
b Fold change in gene expression (sequencing reads) between infected Ad-24 hpi and uninfected cells (mock).
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DAVID annotation analysis showed that the down-regulated
genes primarily were involved in various cellular signaling pathways
including TGF-β, Rho, G-protein, Map kinase, STAT and NF-κB. Inhi-
bition of TGF-β pathway was shown in our previous microarray
study (Zhao et al., 2007). Here, a broader range of genes involved
in TGF-β signaling pathway was identiﬁed (Table 8), which included
the ligands of the TGF-β superfamily (BMP, GDFs and TGFBs), ligandagonist/antagonists, receptors, different SMADs (SMAD3, SMAD6,
SMAD7), and the E3 ubiquitin-protein ligase (SMURF2), as well as
SMAD binding proteins (ZEB2 and TGIF1).
Regulation of genes involved in TGF-β pathway during adenovirus
infection seemed complicated, since both positive and negative regu-
lators were both up- or down-regulated (Table 8). Examples were: 1)
ligands of the superfamily included BMP, GDFs, and TGFΒs; 2) several
antagonists for BMP (NOG and BMPER), TGFΒ/GDF (GREM1, GREM2,
DCN, THBS1, LTBP1 and LTBP2) and activin (INHBA, FST, FSTL1 and
Table 7
Expression of genes implicated in Wnt pathway and downstream targeted genes.
Function Gene
symbol
Gene name Fold change Sequencing reads
Ad-12 hpi Ad-24 hpi Mock Ad-12 hpi Ad-24 hpi
Ligand WNT2 Wingless-type MMTV integration site family member 2 −1.7a −4.1b 95.8 55.3 23.4
WNT5A Wingless-type MMTV integration site family. member 5A 1.0 −5.0 1058.5 1067.4 210.5
WNT5B Wingless-type MMTV integration site family. member 5B −1.3 −5.6 4654.4 3634.3 830.7
WNT7B Wingless-type MMTV integration site family. member 7B 26.3 83.5 0.9 23.8 75.5
Receptor FZD1 Frizzled homolog 1 (Drosophila) 3.5 1.5 182.2 631.4 277.2
FZD5 Frizzled homolog 5 (Drosophila) 4.5 2.6 6.3 28.4 16.7
FZD8 Frizzled homolog 8 (Drosophila) 2.7 −1.4 367.6 1010.2 266.5
FZD9 Frizzled homolog 9 (Drosophila) 5.0 3.4 53.3 265.4 180.3
Coreceptor LRP3 Low density lipoprotein receptor-related protein 3 1.5 2.5 303.1 452.3 768.7
LRP4 Low density lipoprotein receptor-related protein 4 3.2 4.9 31.7 101.2 156.4
LRP6 Low density lipoprotein receptor-related protein 6 2.1 1.9 77.2 160.3 145.6
LRP8 Low density lipoprotein receptor-related protein 8 3.1 3.1 490.1 1533.6 1509.2
Inhibitor MFRP Membrane frizzled-related protein −2.1 −2.4 157.2 75.1 66.2
DKK1 Dickkopf homolog 1 (Xenopus laevis) −4.3 −67.3 1974.5 461.8 29.3
SFRP1 Secreted frizzled-related protein 1 1.1 −2.7 4030.2 4350.5 1518.3
Other SNAI2 Snail homolog 2 (Drosophila) −1.9 −5.1 379.0 199.4 74.4
RRM2 Ribonucleotide reductase M2 1.2 9.2 362.6 452.4 3349.7
APC2 Adenomatosis polyposis coli 2 4.3 7.9 14.2 61.7 112.0
BIRC5 Baculoviral IAP repeat-containing 5 −1.8 3.9 604.4 333.1 2368.4
a Fold change in gene expression (sequencing reads) between infected Ad-12 hpi and uninfected cells (mock).
b Fold change in gene expression (sequencing reads) between infected Ad-24 hpi and uninfected cells (mock).
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INHBE) were up-regulated; 3) the serine/threonine kinase receptors
TGFBR1, TGFBR2, BMPR2, ACVR1 and ACVRL1 were down-regulated,
while BMPR1B and ACVR2B were up-regulated; 4) all three detected
SMADs, SMAD3, SMAD6 and SMAD7, were repressed, whereas
expression of their antagonists, the E3 ubiquitin-protein ligases
SMURF1 and SMURF2 was decreased. However, the net outcome
was clearly that the TGF-β pathway was suppressed efﬁciently,
supported by the facts that nearly all of the TGF-β target genes
were down-regulated. It seemed that repression of genes that en-
code ligands, receptors and SMAD3, as well as the activation of
genes encoding antagonists of ligands was mediated by the virus.
The deregulation of genes implicated in the activation of the path-
way most likely reﬂected the cellular defense. This included the
down-regulation of genes encoding antagonists of ligands and the
E3 ubiquitin ligase and the up-regulation of genes encoding ligands
and their receptors. Our previous Western blot analysis showed
that the expression of SMAD2 and SMAD1/3 at the protein level
remained stable, whereas SMAD4 was increased until late after in-
fection (Zhao et al., 2007). This might present another attempt of
the host cell to counteract the inhibitory effect on the TGF-β pathway
by adenovirus. Adenovirus-induced inhibition of TGF-β pathway
was demonstrated in several earlier studies. E1A has been shown
to block TGF-β-mediated induction of p21, p15 and JunB (Coussens
et al., 1994b; Datto et al., 1997b; de Groot et al., 1995). E1A can
also block growth inhibition by TGF-β through its binding to the
hypophosphorylated pRb (Missero et al., 1991; Pietenpol et al.,
1990) and SMAD proteins (Nishihara et al., 1999). Furthermore, the
TGF-β receptor has been found to be down-regulated in E1A-
transformed keratinocytes (Kim et al., 1997; Missero et al., 1991).
Finally, the regulation of TGF-β pathway was also observed in our
previous microarray study (Zhao et al., 2007). Further studies are
needed to fully elucidate the mechanisms by which the adenovirus
controls the pathway.
Inactivation of NF-κB pathway
Although the DAVID functional annotation analysis did not identi-
fy immune response genes as a signiﬁcant group, the categories “reg-
ulation of signal transduction” and “apoptosis” (Table 3) included
many genes in the NF-κB pathway. Furthermore, Transﬁnd analysis
showed that the NFκB binding site was the second most signiﬁcantmotif among the down-regulated genes, clearly indicating that the
NF-κB pathway was suppressed. As shown in Table 9, expression of
two of the key players of NF-κB pathway, NFKB2 and RelB, was
down-regulated. The activity of NF-κB is primarily regulated by in-
teraction with inhibitory IκB proteins and catalytic activation of the
IκB kinase (IKK). The deregulation of IκB and IKK was, however, not
clear-cut. Among 4 detected IκBs, one (NFKBIB) was up-regulated
and three (NFKBIE, NFκBIA and BCL3) were down-regulated, where-
as among three detected IκB kinases, two (IKBKE and IKBKG) were
down-regulated and one (IΚΒKAP) was up-regulated, indicating a
battle between the virus and its host. Examples of down-regulated
NF-κB target genes were IL6, IL8, F3, BCL3, CCL2, TNFAIP3, THBS1
and INHBA.
A large variety of receptors that trigger NF-κB signaling were
deregulated including genes involved in TNFmediated signaling. A di-
versity of TNF receptors was found to be both up and down-regulated
(Table 10), such as receptors which contained a cytoplasmic death do-
main (TNFRSF10A, TNFRSF1A, TNFRSF25), receptors which contained
a TNF-receptor associated factor (TRAF)-interacting motif in their
cytoplasmic domain (TNFRSF1B, TNFRSF11A, TNFRSF12A, TNFRSF8
and TNFRSF19), as well as receptors which contained no signaling
motif (TNFRSF11B) but competed with the other two groups of recep-
tors for ligands. However, down-regulation of TNFRSF1A, a major re-
ceptor for the TNFα, and its downstream adaptor protein, TRADD,
FADD, R1PK1 and IAP1, indicated suppression of the TNF signaling
pathway. In contrast, the signaling mediated through TNF receptors
with a TRAF-interacting motif was inconsistent as three out of 5
were up-regulated, whereas their adaptor proteins TRAF3 and TRAF1
were up- and down-regulated, respectively. In addition to NF-κB sig-
naling, TNF signaling also leads to apoptosis and other inﬂammatory
processes. Therefore, it is essential for the adenovirus to suppress
this signaling pathway.
Complex deregulation of the apoptosis pathways
The occurrence of E1A induced p53-dependent apoptosis and E1B
protein mediated suppression has been shown before (White, 2001).
Our present study provided a comprehensive view of how cellular
genes involved in apoptosis were deregulated. Both the TNF signal-
ing pathway through the death receptor system and the stress in-
duced Bcl inhibitory pathway were targeted. Expression of several
Bcl2 family members and their transcriptional regulators changed
Table 8
Expression of genes implicated in TGF-β pathway and SMAD targeted genes.
Function Gene
symbol
Gene name Fold change Sequencing read
Ad-12 hpi Ad-24 hpi Mock Ad-12 hpi Ad-24 hpi
Ligand BMP6 Bone morphogenetic protein 6 1.1a 2.1b 150.8 167.5 317.7
GDF1 Growth differentiation factor 1 3.3 7.7 59.1 193.2 455.6
TGFBRAP1 Transforming growth factor. beta receptor associated protein 1 1.8 2.1 284.1 515.3 586.1
GDF15 Growth differentiation factor 15 −1.2 −4.5 857.3 689.7 189.3
GDF5 Growth differentiation factor 5 −1.6 −16.5 268.4 163.7 16.3
GDF6 Growth differentiation factor 6 −1.8 −7.0 83.0 46.9 11.9
Ligand agonist & ligand
antagonists
BMPER BMP binding endothelial regulator −1.6 −27.4 197.6 122.6 7.2
INHBB Inhibin. beta B 1.4 5.1 14.4 20.3 72.9
INHBE Inhibin. beta E 1.9 20.2 5.1 9.8 102.8
INHBA Inhibin. beta A −2.0 −5.5 1167.4 599.1 212.0
NOG Noggin −2.6 −12.4 202.9 78.2 16.4
GREM1 Gremlin 1 −1.4 −6.0 15,708.8 11,371.6 2614.9
GREM2 Gremlin 2 −2.9 −19.6 339.6 116.0 17.3
FST Follistatin −2.0 −6.5 8263.6 4059.5 1265.5
FSTL1 Follistatin-like 1 −1.0 −2.2 7126.1 6861.0 3252.2
FSTL3 Follistatin-like 3 (secreted glycoprotein) 1.2 −2.2 1348.8 1598.3 620.4
THBS1 Thrombospondin 1 −3.4 −12.7 20,490.6 6006.6 1609.0
LTBP1 Latent transforming growth factor beta binding protein 1 −1.0 −2.5 15,952.4 15,810.8 6501.1
LTBP2 Latent transforming growth factor beta binding protein 2 1.1 −1.9 2908.4 3208.3 1554.9
DCN Decorin −1.5 −2.2 90,841.8 62,202.2 41,234.0
Receptor TGFBR1 Transforming growth factor. beta receptor 1 −2.4 −7.6 612.9 257.0 80.2
TGFBR2 Transforming growth factor. beta receptor II 1.0 −2.4 2458.3 2491.9 1021.6
BMPR1B Bone morphogenetic protein receptor. type IB 2.2 5.7 4.8 10.5 27.2
BMPR2 Bone morphogenetic protein receptor. type II 1.3 −2.3 179.0 227.2 78.6
ACVR2B Activin A receptor. type IIB 4.3 4.7 6.7 28.4 31.7
ACVRL1 Activin A receptor type II-like 1 −1.3 −2.5 130.3 102.8 52.0
ACVR1 Activin A receptor. type I −1.3 −2.6 875.3 654.4 331.2
SMAD & SMAD regulator SMAD3 SMAD family member 3 −1.3 −3.3 5920.9 4601.2 1818.6
SMAD6 SMAD family member 6 −1.3 −7.7 273.3 210.3 35.7
SMAD7 SMAD family member 7 −1.0 −3.2 289.2 279.2 89.5
SMURF1 SMAD speciﬁc E3 ubiquitin protein ligase 1 −1.1 −2.0 629.3 585.2 311.2
SMURF2 SMAD speciﬁc E3 ubiquitin protein ligase 2 −2.5 −9.9 1772.5 696.6 178.3
TGIF1 TGFB-induced factor homeobox 1 −2.3 −4.6 2170.5 926.6 474.1
TGIF2 TGFB-induced factor homeobox 2 2.2 1.8 92.3 201.1 165.4
TGFBRAP1 Transforming growth factor. beta receptor associated protein 1 1.8 2.1 284.1 515.3 586.1
Targets JUN Jun proto-oncogene −1.2 −4.9 1700.6 1376.1 347.7
JUNB Jun B proto-oncogene 1.6 −3.1 805.6 1259.3 261.0
CDKN1A Cyclin-dependent kinase inhibitor 1A (p21. Cip1) 1.6 −2.7 14,596.5 23,466.6 5492.1
CDKN1C Cyclin-dependent kinase inhibitor 1C (p57. Kip2) −1.1 −3.3 162.3 143.5 49.1
IL6 Interleukin 6 (interferon. beta 2) −10.9 −156.1 681.7 62.6 4.4
COL1A1 Collagen. type I. alpha 1 −1.0 −2.0 47,682.9 45,934.6 23,757.0
IGFBP3 Insulin-like growth factor binding protein 3 −1.9 −9.2 5729.2 2983.7 624.6
SERPINE1 Serpin peptidase inhibitor. clade E member 1 −2.1 −17.3 71,294.6 33,322.1 4114.2
PDGFRB Platelet-derived growth factor receptor. beta polypeptide −1.0 −2.1 1183.8 1152.9 555.3
TGFB1I1 Transforming growth factor beta 1 induced transcript 1 −1.8 −4.6 6962.3 3828.4 1503.7
STAT1 Signal transducer and activator of transcription 1. 91 kDa −1.4 −3.7 1395.6 1018.2 379.2
DAB2 Disabled homolog 2. mitogen-responsive phosphoprotein −3.3 −11.5 1383.1 420.7 120.7
CDC25A Cell division cycle 25 homolog A (S. pombe) 8.0 26.1 106.5 855.7 2781.2
MYC v-myc myelocytomatosis viral oncogene homolog (avian) −1.5 −8.1 1026.0 708.7 126.7
HIPK2 Homeodomain interacting protein kinase 2 1.1 −3.8 1103.2 1157.6 287.0
ID1 Inhibitor of DNA binding 1. dominant negative helix–loop–helix protein −2.6 −24.7 3067.0 1190.4 124.1
ID2 Inhibitor of DNA binding 2. dominant negative helix–loop–helix protein −1.6 −3.7 768.9 486.3 207.5
a Fold change in gene expression (sequencing reads) between infected Ad-12 hpi and uninfected cells (mock).
b Fold change in gene expression (sequencing reads) between infected Ad-24 hpi and uninfected cells (mock).
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apoptotic functions were up- and down-regulated. BCL2L11 (pro-
apoptotic) and BCL2 (anti-apoptotic) were up-regulated whereas
BCL2L1 (anti-apoptotic) and BNIP3L (pro-apoptotic) were down-
regulated. Besides, the pro-apoptotic gene BCLAF1, a transcriptional
repressor of the BCL2 family was also up-regulated. In addition to
the extrinsic apoptosis pathway, the intrinsic apoptosis pathway
was deregulated. The sensors of cellular stress and the critical activa-
tors of apoptosis, the p53 family members, TP53 and TP73 were
both activated. The up-regulation of TP73 was striking, from 29
fold at 12 hpi to more than 300 fold at 24 hpi. One of the important
feature of TP73 is that it cannot be inactivated by E1B (Marin et al.,
1998), but its transcriptional activation can be inhibited by E1A
(Das et al., 2003). Apart from activating transcription of the majority
of the p53-responsive genes, TP73 can also promote transcription ofanother set of genes (Fontemaggi et al., 2002). One of the example
was the activation of JAG2 (ligand for Notch signaling pathway)
gene.
Adenovirus-mediated suppression of STAT pathway
The signal transducer and activators of transcription (STAT) pro-
teins have a crucial role in host defense. Expression of ﬁve out of 7
detectable of STATs (expression of STAT4 and STAT5A was very
low in IMR-90 cell line as indicated by the number of sequencing
reads) was down-regulated (Table 11). The down-regulation of
STAT1, STAT2 and STAT6 was prominent. Consistently, expression
of the interferon regulatory factor IRF9 was also down-regulated.
STAT1, STAT2 and IRF9 form a heterotrimer complex, so called IFN-
stimulated gene factor 3 (ISGF-3). The ISGF-3 complex binds to
Table 9
Deregulation of genes implicated in NF-kB pathway.
Function Gene
symbol
Gene name Fold change Sequencing reads
Ad-12 hpi Ad-24 hpi Mock Ad-12 hpi Ad-24 hpi
NF-κB NFKB2 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) −1.4a −2.4b 2499.9 1760.7 1063.4
RELB v-rel reticuloendotheliosis viral oncogene homolog B −1.8 −3.9 473.9 257.6 121.3
NF-κB inhibitor NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor. alpha −1.3 −3.4 797.6 613.7 234.9
NFKBIB Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor. beta 1.8 4.8 748.1 1362.8 3570.8
NFKBIE Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor. epsilon −3.3 −10.2 254.6 77.9 25.0
BCL3 B-cell CLL/lymphoma 3 −1.2 −3.5 434.9 378.1 124.0
IκB kinase IKBKAP Inhibitor of kappa light polypeptide gene enhancer in B-cells. kinase
complex-associated protein
2.1 2.4 126.3 269.6 303.8
IKBKE Inhibitor of kappa light polypeptide gene enhancer in B-cells. kinase epsilon −1.8 −6.0 329.4 183.1 54.6
IKBKG Inhibitor of kappa light polypeptide gene enhancer in B-cells. kinase gamma −1.5 −2.2 1641.7 1118.3 741.6
NF-κB regulator NFKBIL2 Tonsoku-like. DNA repair protein 2.5 11.3 112.9 286.8 1276.3
a Fold change in gene expression (sequencing reads) between infected Ad-12 hpi and uninfected cells (mock).
b Fold change in gene expression (sequencing reads) between infected Ad-24 hpi and uninfected cells (mock).
124 H. Zhao et al. / Virology 424 (2012) 115–128ISRE DNA elements and induces expression of IFN target genes. This
is the type I interferon (IFNα/β) pathway, which is very crucial in
establishing an initial line of defense and is, therefore, the primary
target of the viral immune evasion system (Goodbourn et al., 2000;
Parisien et al., 2002). In addition, effectors and negative regulators
were also differentially expressed. The effectors STAM and STAM2,
adapter molecules, which can facilitate the transcription of speciﬁc
target genes, were down-regulated. Members from all three major
classes of negative regulators SOCS, PIAS, and PTPs were found to
be deregulated. Most of them were down-regulated except SOCS4
and PIAS2. SOCS proteins block signaling from the receptor to the
STATs, PIAS proteins block DNA binding of STATS, and PTPs dephos-
phorylate and deactivate JAK2, TYK2 and STAT5. Apparently, the
adenovirus-mediated inhibition of the STAT pathway occurred at
many steps. Host-mediated activation of the STAT pathway
appeared to be limited, and mostly occurred through the activation
of the negative regulators SOCS4 and PIAS2.
Previously we have studied and compared the changes in gene ex-
pression during infections with adenovirus type 2 and type 12 (Zhao
et al., 2009). Ad2 replicates efﬁciently in IMR-90 cells and gives rise to
a very strong cytopathic effect, as well as signiﬁcant changes of cellu-
lar gene expression, whereas under the same conditions, Ad12 gives
rise to a slower replication cycle and no signiﬁcant cytopathic effect.
In addition 4 times as many genes were differentially expressed in
Ad2 infected cells as compared to Ad12-infected cells. One of the
major differences was the deregulation of the STAT pathway. In
Ad2-infected cells, expression of STAT3 and several cytokines was
down-regulated. In Ad12-infected cells, in contrast, expression of
STAT1, STAT2, as well as a numerous interferon-inducible genes,
was up-regulated. Our present results showed that the STAT pathway
was inhibited at multiple levels during Ad2 infection.
Deregulation of genes that encode cytokines and their receptors
Among various types of cytokines, deregulation of interleukins
and their receptors was the most striking. The expression of all
detected interleukins was rapidly reduced to a very low level
(Table 11) from 12 hpi and continuing at 24 hpi. In contrast, the
deregulation of interleukin receptors was inconsistent. Most of
them, such as IL12RB2, IL17RB, IL17RD, IL6R, and IL20RB were up-
regulated and signiﬁcant activation occurred from 12 hpi, whereas
only three, including IL1R, IL4R, and IL7R, were down-regulated
which became signiﬁcant after 24 hpi. The inconsistency of the
deregulation of interleukins and their receptors could be interpreted
as the results of the struggle between the virus and its host. Among
differentially expressed cytokines, members of the IL-6 family (LIF,
IL-11, IL-6, and CTF1) were noteworthy. All of them were down-
regulated, IL6 more than 100-fold, whereas IL11 showed a 37-fold
decrease. IL-6 is a multifunctional cytokine that plays a central rolein host defense because of its wide range of immune and hematopoi-
etic activities and its ability to induce the acute phase response.
Many of the biological effects of IL-11 overlap those of IL-6. IL-11 is
a multifunctional IL-6 type of cytokine with diverse biologic proper-
ties, including the ability to stimulate hematopoietic, thrombopoi-
esis and megakaryocytopoiesis. LIF is involved in the induction of
hematopoietic differentiation in normal and myeloid leukemia
cells. Furthermore, the IL-6 family binds to IL-6RB, which in turn ac-
tivates the Janus kinase and ﬁnally, leads to the activation of STAT1
and STAT3. Thus, strong and rapid inhibition of cytokines might rep-
resent another mechanism for suppression of the host antiviral im-
mune response. To overcome the loss of cytokines, the host cell
seemed to activate some speciﬁc cytokine receptors which, howev-
er, did not seem to help.
Consistent with previous microarray studies
The temporal alternations of cellular gene expression following
adenovirus infection of ﬁbroblast cells have been studied by using mi-
croarray technology (Miller et al., 2007; Zhao et al., 2007). In IMR-90
cells, expression of over 460 cellular genes was changed during the
early phase (from 6 to 24 hpi) of an adenovirus type 2 infection. In
the present study, by using sequencing technology, 3791 cellular
genes were identiﬁed as differentially expressed more than 2 fold,
which was eight times more. In general, our sequencing results cor-
roborated the earlier microarray results, but provided a great deal of
additional information. Over 70% of the genes that were differentially
expressed from 6 to 24 hpi identiﬁed by microarray technology were
conﬁrmed here. It is noteworthy that about 50% of the identiﬁed
genes that have known functions were involved in control of cell
cycle, cell growth, and antiviral response. The deregulation of genes
involved in cell cycle regulation, such as CCNE1, CCNE2, CCNA2,
CDCA5, CDK4, CDC45L, CDC25A, CDC6 could be detected in both stud-
ies. However, the list of genes in this functional category was much
longer and much more quantitative in present study. Another consis-
tent result was the activation of the Wnt pathway, the inhibition of
TGF-β, STAT, NF-κB pathway, as well as the down-regulation of cyto-
kines. In the TGF-β pathway, as many as 26 additional genes were dis-
covered in the present study (see Table 8).
Miller et al. (2007) have studied alterations in the cellular tran-
scription reprogram in human foreskin ﬁbroblast cells after adeno-
virus type 5 infection by using microarrays with 44,000 reference
points. They observed that the expression of about 2000 genes in-
creased or decreased more than 2-fold. Cellular RNAs that were
up-regulated early in infection were assigned important functions
related to cellular proliferation included cell cycle check point pro-
teins, DNA replication licensing proteins and cell cycle promoting
transcription factors. Genes encoding proteins that mediate or regu-
late DNA replicationwere highly enriched, including genes encoding
Table 10
Deregulation of genes implicated in apoptosis.
Gene
symbol
Gene name Fold change Sequencing reads
Ad-12 hpi Ad-24 hpi Mock Ad-12 hpi Ad-24 hpi
TNFSF4 Tumor necrosis factor (ligand) superfamily, member 4 −5.0a −15.5b 315.1 63.0 20.3
EDA Ectodysplasin A 37.2 80.2 0.7 26.6 57.4
TNFRSF1A Tumor necrosis factor receptor superfamily. member 1A −1.2 −2.7 1439.4 1171.5 535.5
TNFRSF25 Tumor necrosis factor receptor superfamily. member 25 1.1 −2.1 588.2 632.9 283.2
TNFRSF10A Tumor necrosis factor receptor superfamily. member 10a 2.6 6.9 33.9 87.2 235.4
TNFRSF1B Tumor necrosis factor receptor superfamily. member 1B 1.5 2.1 207.8 306.3 433.5
TNFRSF11A Tumor necrosis factor receptor superfamily. member 11a. NFKB activator 11.4 86.1 0.3 3.2 24.4
TNFRSF8 Tumor necrosis factor receptor superfamily. member 8 4.7 27.0 6.1 29.0 165.7
TNFRSF12A Tumor necrosis factor receptor superfamily. member 12A −2.0 −6.3 7154.4 3525.6 1144.0
TNFRSF11B Tumor necrosis factor receptor superfamily. member 11b −5.2 −19.4 2460.1 470.6 126.6
TRADD TNFRSF1A-associated via death domain −1.2 −2.9 248.9 214.5 85.3
FADD Fas (TNFRSF6)-associated via death domain −1.3 −2.5 785.7 597.5 312.0
TRAF1 TNF receptor-associated factor 1 −2.2 −2.8 83.5 38.6 29.9
TRAF3 TNF receptor-associated factor 3 1.4 2.4 777.5 1092.9 1857.3
TRAF3IP2 TRAF3 interacting protein 2 −1.6 −3.2 580.7 364.7 178.7
TRAIP TRAF interacting protein −1.1 3.5 42.8 40.6 149.8
TRAP1 TNF receptor-associated protein 1 1.4 2.8 801.7 1148.4 2260.7
RIPK1 Receptor (TNFRSF)-interacting serine–threonine kinase 1 1.3 −2.0 204.5 271.3 100.6
DEDD Death effector domain containing −1.2 −2.3 1069.4 867.6 458.9
DEDD2 Death effector domain containing 2 −1.4 −2.6 352.0 259.0 137.5
TP53 Tumor protein p53 1.0 1.9 2442.9 2392.5 4733.4
TP73 Tumor protein p73 29.3 311.6 4.8 140.6 1494.0
CFLAR CASP8 and FADD-like apoptosis regulator −1.6 −4.0 805.6 504.5 200.1
CASP1 Caspase 1. apoptosis-related cysteine peptidase −2.1 −3.9 917.2 447.2 236.8
CASP4 Caspase 4. apoptosis-related cysteine peptidase −2.0 −3.2 2477.8 1262.3 772.6
CASP7 Caspase 7. apoptosis-related cysteine peptidase 1.7 2.2 287.0 499.6 619.6
CASP8AP2 Caspase 8 associated protein 2 2.5 2.1 156.2 392.7 334.6
BCL10 B-cell CLL/lymphoma 10 −1.8 −3.3 100.2 55.3 30.5
BCL2 B-cell CLL/lymphoma 2 7.4 10.8 8.0 59.3 86.8
BCL2L1 BCL2-like 1 −1.7 −4.5 2497.7 1499.4 558.8
BCL2L11 BCL2-like 11 (apoptosis facilitator) 14.1 28.4 25.4 359.5 722.1
BCLAF1 BCL2-associated transcription factor 1 1.1 2.6 706.7 776.0 1814.1
BAG3 BCL2-associated athanogene 3 −1.8 −2.3 1802.8 980.8 777.8
BNIP3L BCL2/adenovirus E1B 19 kDa interacting protein 3-like −2.4 −3.8 497.1 207.2 131.6
a Fold change in gene expression (sequencing reads) between infected Ad-12 hpi and uninfected cells (mock).
b Fold change in gene expression (sequencing reads) between infected Ad-24 hpi and uninfected cells (mock).
125H. Zhao et al. / Virology 424 (2012) 115–128subunits of DNA polymerase, MCM complex components, and pro-
teins that regulate spindle formation, chromosome condensation,
segregation etc. Furthermore, among down-regulated genes, those
involved in cell communication, signal transduction and develop-
ment were also signiﬁcant during the adenovirus type 5 infection.
Thus the present results are consistent with this study and our own
microarray studies (Zhao et al., 2007).
In the present study we have used state of the art technologies
to study the changes in host cell gene expression that were caused
by an adenovirus infection. The data obtained was much more pre-
cise and quantitative compared to the studies reported by us and
others (Miller et al., 2007; Zhao et al., 2007). In addition, a number
of bioinformatics tools have become available since earlier reports
and these were applied to the huge data set that our study gener-
ated. A weak point is that RNA was analyzed at only two time
points after infection due to the high cost of sequence analysis.
Another shortcoming is the difﬁculty to deﬁne whether deregula-
tion of gene expression is caused by viral gene products or reﬂect
the host cell responses to the infection. Nonetheless, our RNA se-
quencing studies are one step further towards the understanding
of interaction between adenovirus and its host cell. Insights from
such studies shed light on how viruses take control of the infected
cell and should ultimately identify new general targets for the
design of anti-viral substances. Furthermore, our high quality se-
quence data base provides a valuable resource for studying gene
regulation and gene function when novel analytical tools become
available.Materials and methods
Cell culture and adenovirus infection
Human primary lung ﬁbroblast cells (IMR-90) (American Type
Culture Collection) were cultured in Eagle's minimum essential me-
dium (MEM) with Earle's salt and GlutaMAX™ supplemented with
10% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomy-
cin, 0.1 mM nonessential amino acids, 1.5 g/l sodium bicarbonate
and 1.0 mM sodium pyruvate. The IMR-90 cells were synchronized
by growth inhibition through cultivation for two days after conﬂu-
ence, as described previously (Zhao et al., 2007). Synchronized
monolayer cells were mock-infected or infected with Ad2 at a multi-
plicity of 100 ﬂuorescence-forming units (FFU) per cell (Philipson,
1961) in serum-free medium. After 1 h adsorption at 37 °C, the me-
dium was replaced with MEM containing 10% FBS and incubated at
37 °C. Infected cells were collected at 6, 12, 24, 36 and 48 hours
post infection (hpi). Mock-infected cells were collected at 6 hpi.
However, only 12 and 24 hpi as well as mock infection were sub-
jected to the sequencing analysis. According to our previous experi-
ments, no dramatic change was observed between 6 and 48 h in
mock-infected cells.
RNA extraction, cDNA library preparation and sequencing
Total RNA from adenovirus or mock-infected IMR-90 was extracted
using TRIZOL Reagent (Invitrogen). The quantity and quality of the RNA
Table 11
Deregulation of genes involved in STAT signaling pathway and genes encoded cytokines and cytokine receptors/regulators.
Function Gene
symbol
Gene name Fold change Sequencing reads
Ad-12 hpi Ad-24 hpi Mock Ad-12 hpi Ad-24 hpi
STAT signaling STAT1 Signal transducer and activator of transcription 1 −1.4a −3.7b 1395.6 1018.2 379.2
STAT2 Signal transducer and activator of transcription 2 −1.5 −4.9 330.0 225.3 67.7
STAT3 Signal transducer and activator of transcription 3 −1.2 −1.9 1726.4 1470.6 913.3
STAT6 Signal transducer and activator of transcription 6 −1.3 −2.4 871.4 645.8 357.1
STAT5A Signal transducer and activator of transcription 5A 1.4 −1.2 62.8 86.3 51.0
STAT5B Signal transducer and activator of transcription 5B −1.1 −1.5 209.8 194.6 141.9
STAT4 Signal transducer and activator of transcription 4 −1.5 1.1 4.5 3.0 5.1
IRF9/p48 Interferon regulatory factor 9 −1.5 −4.0 254.9 175.5 63.1
SOCS2 Suppressor of cytokine signaling 2 −2.3 −3.0 244.5 107.9 82.3
SOCS4 Suppressor of cytokine signaling 4 2.2 7.0 95.8 211.4 667.4
SOCS5 Suppressor of cytokine signaling 5 −1.5 −5.0 751.4 510.9 149.4
PIAS2 Protein inhibitor of activated STAT. 2 1.4 2.0 176.9 250.5 355.1
PIAS3 Protein inhibitor of activated STAT. 3 −1.2 −3.7 671.8 564.4 179.7
PTPN1 Protein tyrosine phosphatase. non-receptor type 1 −1.8 −2.1 679.6 384.0 318.6
STAM Signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 −1.83 −2.27 249.02 135.83 109.65
STAM2 Signal transducing adaptor molecule (SH3 domain and ITAM motif) 2 −1.18 −3.05 128.49 109.30 42.11
Cytokines. Cytokine
receptors & regulators
IL6 Interleukin 6 (interferon. beta 2) −10.9 −156.1 681.7 62.6 4.4
IL8 Interleukin 8 −4.0 −20.4 238.9 59.8 11.7
IL11 Interleukin 11 −2.6 −37.0 1033.3 404.4 28.0
IL15 Interleukin 15 −4.2 −7.9 95.4 22.5 12.1
IL12A Interleukin 12A −3.6 −12.6 135.5 38.2 10.8
LIF Leukemia inhibitory factor −5.4 −8.3 4313.2 801.9 520.7
IFNA1 Interferon. alpha 1 −17.0 −71.0 71.7 17.7 0.0
IFNE Interferon. epsilon −4.0 −50.0 131.6 32.9 2.6
CCL2 Chemokine (C-C motif) ligand 2 −19.0 −219.7 6090.8 321.3 27.7
CTF1 Cardiotrophin 1 −2.4 −7.9 282.1 118.7 35.7
CXCL16 Chemokine (C-X-C motif) ligand 16 3.9 8.0 26.7 103.2 212.8
IL12RB2 Interleukin 12 receptor. beta 2 13.4 118.2 0.4 5.9 51.8
IL17RB Interleukin 17 receptor B 4.1 14.9 20.8 85.1 310.8
IL17RD Interleukin 17 receptor D 3.5 1.9 9.9 34.4 18.9
IL1R1 Interleukin 1 receptor. type I −1.2 −2.0 273.3 232.0 135.5
IL1RAP Interleukin 1 receptor accessory protein −1.6 −2.4 233.5 144.2 97.2
IL20RB Interleukin 20 receptor beta 1.1 5.8 9.5 10.7 55.0
IL4R Interleukin 4 receptor −1.2 −2.3 1100.1 928.5 482.9
IL6R Interleukin 6 receptor 4.6 5.5 23.6 109.3 130.7
IL7R Interleukin 7 receptor −1.7 −12.3 741.7 445.1 60.2
LIFR Leukemia inhibitory factor receptor alpha 2.0 1.7 51.8 104.1 89.9
CXCR4 Chemokine (C-X-C motif) receptor 4 11.8 63.0 0 11.8 62.9
CRLF3 Cytokine receptor-like factor 3 1.2 2.1 72.5 86.7 154.1
IRAK2 Interleukin-1 receptor-associated kinase 2 −1.2 −2.6 118.8 98.8 45.0
IRAK3 Interleukin-1 receptor-associated kinase 3 5.4 9.4 6.8 36.7 63.7
IRF5 Interferon regulatory factor 5 3.1 7.4 7.9 24.0 58.3
IFI30 Interferon. gamma-inducible protein 30 2.0 5.6 39.4 78.8 222.6
CNTF Ciliary neurotrophic factor 1.5 6.2 18.2 27.5 113.3
a Fold change in gene expression (sequencing reads) between infected Ad-12 hpi and uninfected cells (mock).
b Fold change in gene expression (sequencing reads) between infected Ad-24 hpi and uninfected cells (mock).
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400 (Agilent Technologies). The cDNA libraries were prepared using
Illumina mRNA Seq sample preparation kits (RS-100-0801) according
to the manufacturer's protocol (Part # 1004898 Rev A). Single-end se-
quencing was performed using an Illumina Genome Analyzer II
instrument.
Data collection and mapping of reads
The three sets of reads (mock, Ad-12 h and Ad-24 h) from the Illu-
mina sequencing were aligned to both a human reference genome
[GRCh37/hg19] and an adenovirus reference genome [http://www.
ncbi.nlm.nih.gov/nuccore/AC_000007, 12/2008] using the software
Bowtie (Langmead et al., 2009) and using the default parameters.
The resulting alignments were loaded into R [R Development Core
Team (2010). R: A language and environment for statistical computing.
R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-
900051-07-0, URL http://www.R-project.org/] and all the reads that
mapped to exons according to gene annotations (RefSeq Genes)
from UCSC Genome Browser (Kent et al., 2002) were extracted. All
overlapping splice variants of genes were merged and the gene anno-
tations comprised 23,162 unique genes. The read counts (the numberof mapped reads) for individual exons were summarized to read
counts for the corresponding genes. All R code used in the analysis
is available upon request.
Data analysis
The proportionality test function in the stats package to R was ap-
plied to each gene using the read-count in each data set and the total
size of each data set. This function calculates the probability that the
gene has the same proportion of reads at the three time points, i.e.
that it is not differentially expressed. The reads for genes from differ-
ent time points were normalized in regard to the time points total
data set size. To avoid distortion of this analysis due to the large por-
tion of adenovirus reads in the 24 hpi sample, the human and adeno-
virus genomes were analyzed separately. Differentially expressed
genes were identiﬁed as signiﬁcant if their expressions were more
than 2-fold changes and with a proportionality test p-valueb1E−20.
Expression analysis
The web based software DAVID (Huang da et al., 2009a,b) was used
to perform a gene ontology enrichment analysis of the differentially
127H. Zhao et al. / Virology 424 (2012) 115–128expressed genes. The annotated genes from the RefSeq data set were
used as background. This analysis searched for biochemical path-
ways and gene ontologies that were overrepresented in our sample,
compared to a random sample of equal size from the background list.
A k-means clustering based on the normalized expression proﬁle
of each gene was also made with the program Genesis (Sturn et al.,
2002). The normalization was done to get a rough image of the
shape of the expression proﬁle. The clusterswere then subjected to on-
tology enrichment and overrepresented transcription factor binding
motifs analyses (as described below).
Transcription factor binding sites
Transﬁnd (http://transﬁnd.sys-bio.net/) looks for areas in the pro-
moter region of a set of genes that are likely to bind to known tran-
scription factors (TFs) (Kielbasa et al., 2010). If all the genes in a set
show an over representation of the same TF, it is likely that they are
all regulated by that TF. This analysis was applied to the gene set
after a clustering based on expression proﬁle.
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